FDA Inspection
Azurity Pharmaceuticals, Inc.Azurity Pharmaceuticals, Inc. – FDA Inspection, Mar 2, 2023
Record Details
This FDA Inspection record concerns Azurity Pharmaceuticals, Inc., with an inspection on March 2, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 64bfb086-1201-4189-ba58-78d85ea96314
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1200074
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Azurity Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Azurity Pharmaceuticals, Inc.
- FDA Inspection 1255484 - 2024-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.